Warning: There are an increasing number of fraudulent websites that impersonate the ECCMID. We would like to alert all our members and delegates to be aware of possible scams and to strongly advise you to only use the official ECCMID online registration and accommodation services for your bookings.

Scientific Symposia

One-hour Symposia


Measles, old and new threat
Current status of vaccination against measles in Europe
Management of measles outbreaks in 2018
Co-arranged with Österreichische Gesellschaft für Hygiene, Mikrobiologie und Präventivmedizin (ÖGHMP)

Viruses in transplantation - not always enemies
Value of viraemia to evaluate the net state of immunosuppression (EBV, TT virus)
Virome and transplantation
Co-arranged with ESGICH - ESCMID SG for Infections in Compromised Hosts

Trending topics in sepsis
The microbiome in sepsis: from pathogenesis to novel treatments
Long-term outcomes of sepsis
Co-arranged with International Sepsis Forum (ISF), ESGBIS - ESCMID SG for Bloodstream Infections and Sepsis

Challenging breakpoints with supranormal dosing
Next-generation clinical breakpoints taking into account the infection site, dosing and administration?
Where is the limit in terms of side effects with higher dosing, and can toxicodynamics help?
Co-arranged with EPASG - ESCMID PK/PD of Anti-Infectives SG, EUCAST - European Committee on Antimicrobial Susceptibility Testing

To use or not to use corticosteroids for community-acquired pneumonia?
(Pro/Con debate)
PRO
CON

A fresh look at enterococci
Understanding antibiotic resistance in enterococci
Clinical and therapeutic challenges of enterococcal infection in the 21st century

Update on bartonellosis and Q fever
Update on bartonellosis
Update on Q fever
Co-arranged with ESGBIS - ESCMID SG for Bloodstream Infections and Sepsis

A China - Europe axis of developing antimicrobial resistance monitoring
Status and results of the China Antimicrobial Resistance Surveillance System network
European antimicrobial resistance monitoring networks - global level perspectives
Co-arranged with Chinese Medical Association/China International Medical Foundation (CMA/CIMF), ESGARS - ESCMID SG for Antimicrobial Resistance Surveillance, International Affairs Subcommittee

Antimicrobial resistance in sexually transmitted bacterial infections
Global challenge of antibiotic-resistant Mycoplasma genitalium
Evolution of antimicrobial resistance in Neisseria gonorrhoeae
Co-arranged with ESGMI - ESCMID SG for Mycoplasma Infections, ESGARS - ESCMID SG for Antimicrobial Resistance Surveillance

Resistance to new cephalosporin-inhibitor combinations - mechanisms and clinical significance
Mechanisms of resistance to ceftazidime-avibactam
Mechanisms of resistance to ceftolozane-tazobactam
Co-arranged with ESGARS - ESCMID SG for Antimicrobial Resistance Surveillance

Resistance in anaerobic bacteria - mechanisms and clinical implications
Metronidazole resistance in anaerobic bacteria on the move?
How to deal with carbapenem resistance and multi-drug resistance in Bacteroides fragilis
Co-arranged with ESGAI - ESCMID SG for Anaerobic Infections, EUCAST - European Committee on Antimicrobial Susceptibility Testing

Reservoirs of antimicrobial resistance genes
Water and soil as reservoirs for MDR genes
Animals and MDR bacteria
Co-arranged with ESGVM - ESCMID SG for Veterinary Microbiology, EFWISG - ESCMID Food- and Water-borne Infections SG, ESGARS - ESCMID SG for Antimicrobial Resistance Surveillance, ESGS - ESCMID SG for Staphylococci and Staphylococcal Diseases

New advances in the molecular detection of atypical agents of respiratory tract infections
Detection of Mycoplasma pneumoniae infections and outbreak management 
Molecular detection and typing of Legionella infections

Co-arranged with ESGMI - ESCMID SG for Mycoplasma Infections, ESGMD - ESCMID SG for Genomic and Molecular Diagnostics, ESGLI - ESCMID SG for Legionella Infections

Whole-genome sequencing and anaerobes
WGS of anaerobic bacteria: a whole new world!
Approaches to and applications of WGS analysis of C. difficile

Co-arranged with ESGMD - ESCMID SG for Genomic and Molecular Diagnostics, ESGAI - ESCMID SG for Anaerobic Infections, ESGCD - ESCMID SG for Clostridium difficile

Year in Clinical Microbiology
Talk 1
Talk 2

Angels and devils: bacteriological weapons against bacterial diseases
Human commensals producing novel antibiotics to impair pathogen colonization
Predatory bacteria as living antibiotics

Old antibiotics with a new life
Fosfomycin: recent insights
Minocycine and rifampin: achievements and prospects

Co-arranged with ESGIE - ESCMID SG for Infections in the Elderly

No more debate: shortening therapy for bloodstream infection and deescalation
Shortening therapy for bloodstream infection
Deescalation as a critical strategy in acute care

Co-arranged with ESGAP - ESCMID SG for Antimicrobial stewardshiP, ESGBIS - ESCMID SG for Bloodstream Infections and Sepsis

Drug discovery challenges
Getting antibiotics to their target
Studying cross-resistance in drug discovery

Top papers in mycology
Clinical mycology
Laboratory mycology

Co-arranged with EFISG - ESCMID Fungal Infection SG

Influenza-associated aspergillosis
Aspergillosis in patients with flu?

The interaction between influenza and Aspergillus

Co-arranged with EFISG - ESCMID Fungal Infection SG

Top papers in neglected tropical diseases
Diagnostic parasitology
Clinical parasitology and epidemiology

Co-arranged with ESGCP - ESCMID SG for Clinical Parasitology

Migrants and refugees welcome - a discussion of infection prevention and control
When we were migrants: European migration to the Americas
Current guidance on screening and vaccination of recently arrived migrants and refugees in Europe - evidence, consensus, controversy

Co-arranged with ESGITM - ESCMID SG for Infections in Travellers and Migrants, EVASG - ESCMID Vaccine SG, International Affairs Subcommittee

Fixing gaps in infection control guidelines
The limitations of evidence-based recommendations in infection control guidelines
How to deal with evidence and the strength of recommendations in infection control guidelines

Year in Infection Control
Talk 1
Talk 2

Imaging microbes in 3D
Probing microbes and their interaction with host cells using atomic force microscopy
Following cell invasion by pathogenic bacteria in real time using correlative ion beam/ scanning electron tomography and FRET technologies

The value of standard susceptibility testing for biofilms – a pro/con debate
PRO
CON
Co-arranged with ESGB - ESCMID SG for Biofilms, EPASG - ESCMID PK/PD of Anti-Infectives SG


Extracellular vesicles – key mediators in intercellular communication and roles in infection pathogenesis and prevention

Extracellular vesicles in intercellular communication networks – concepts

Understanding the role of extracellular vesicles in the pathogenesis and prevention of bacterial infection

Immunogenetics of infectious diseases 
Fungal infections
Viral infections

Should we continue giving influenza vaccines repeatedly?
What do we know of the immunological impact of repeated influenza vaccinations?
What does the epidemiological data on influenza vaccine effectiveness tell us?

Pneumococcus/Haemophilus influenzae/RSV triumvirate in childhood respiratory infections - potential effects of vaccines
Pneumococcal conjugate vaccines - how do they impact on respiratory disease beyond the pneumococcus?
RSV vaccines in development - what is their expected impact on respiratory tract microbiome and disease?

Bioterrorism preparedness: molecular update
Microbial forensics – unbeatable tool in bioterrorism preparedness
European interlaboratory exercises for preparedness

Co-arranged with ESGMD - ESCMID SG for Genomic and Molecular Diagnostics, ESGFOR - ESCMID SG for Forensic and Postmortem Microbiology

Three problematic “P”s in clinical microbiology and infectious diseases publishing: plagiarism, piratism and predatorism
Avoiding plagiarism, self-plagiarism, fabrication, and falsification: a guide to ethical writing in clinical microbiology and infectious diseases
Publishing pirates, predatory publishers, predatory journals and vanity conferences: threat to research and medical practice

Year in Infectious Diseases
Talk 1
Talk 2

Young Investigator Award Lectures

Two-hour Symposia


Influenza and other respiratory viruses

After the Spanish Flu: lessons learned from 1957 and 1968
Lessons from the 2009 influenza pandemic
Community-acquired pneumonia in children - update from the PERCH study
Diagnostic dilemmas in respiratory viruses: point-of-care, multiple tests, targeted molecular tests

Arboviruses: resurgence of a past neglected problem
Risk of yellow fever urbanization in endemic areas of dengue
Epidemiological effect of Wolbachia for dengue and other arbovirus control
New perspectives of novel Zika and dengue vaccines
New anti-mosquito and larvicidal agents in the lab and in the field

New horizons in hepatitis B, D and E
Who should be treated in 2018 for hepatitis B?
Novel approaches towards hepatitis B cure
Hepatitis D: 40 years later
Hepatitis E: its effect on the liver and beyond
Co-arranged with ESGVH - ESCMID SG for Viral Hepatitis

Novel approaches in functional cure and prevention of HIV/AIDS
Treatment of HIV during acute and early phase of infection
Paediatric HIV infection: the potential for cure 
Immunotherapy of HIV
Vaccines against HIV: current development and future perspective

Microbes and pregnancy: compelling questions and emerging answers
Does the maternal microbiome influence pregnancy outcomes?
How do bacteria cause chorioamnionitis?
Does the placenta really protect the foetus from infection?
Bacteria as causes of stillbirth: what do we really know?
Co-arranged with American Society for Microbiology (ASM)

Diagnosing, combatting, and preventing bone and joint infections

Biofilms: state of the art on the problem
Differential diagnosis of prosthetic joint infections 
Diagnostic technologies
What is new in treatment and prevention?

Hot topics in mycobacterial infections
Clinical relevance of genetic diversity of TB
The role in research of imaging and biomarkers in tuberculosis
Short treatment for tuberculosis: is it in sight?
The aerobiology of TB - how and when does transmission happen?
Co-arranged with ESGMYC - ESCMID SG for Mycobacterial Infections

What's new in Staphylococcus aureus?
Mechanisms for S. aureus long-term persistence in host tissue
Hiding in plain sight - host-cell receptors that determine toxin tissue specificity
What makes a pathogen host specific?
Importation of global MRSA clones into Europe
Co-arranged with ESGS - ESCMID SG for Staphylococci and Staphylococcal Diseases, ESGBIS - ESCMID SG for Bloodstream Infections and Sepsis

Klebsiella pneumoniae – novel insights into a key pathogen
Hypervirulent Klebsiella pneumoniae: an emerging pathotype poised to inflict global havoc
The evolution of antimicrobial-resistant clones of Klebsiella pneumoniae – genomic insights
Virulence determinants of Klebsiella causing liver abscess in otherwise healthy hosts
Persisting intrahospital transmission of multidrug-resistant Klebsiella pneumoniae and challenges for infection control
Co-arranged with ESGBIS - ESCMID SG for Bloodstream Infections and Sepsis

Individualized antimicrobial therapy – is it worth it?
Real-time antimicrobial sensing - closing the loop on precision antimicrobial therapy
Rapid diagnostics and genome sequencing for optimizing treatment of severe infections
Do we need beta-lactam TDM or can we just use prolonged infusions?
Therapeutic drug monitoring in invasive fungal infections

Co-arranged with EPASG - ESCMID PK/PD of Anti-Infectives SG

From plasmids and transposons to whole-genome sequence: a new story begins in Latin America
How the story began: the finding of KPC
The transposon perspective during the outbreak in Colombia
The whole-genome sequence perspective: a totally different story
Rapid molecular diagnostics informing antibiotic treatment decisions

Co-arranged with International Affairs Subcommittee

Bacteriophages for antimicrobial therapy – what is the current evidence?
Early experience with phage therapy
Perspectives for clinical applications of phage therapy
Phagoburn – a randomised clinical phage trial
Regulatory aspects of phage therapy

'Stubborn' infections in transplant patients - from recurrence to resistance
Recurrent urinary tract infections in kidney transplant patients
Management of multidrug-resistant colonization in cystic fibrosis patients undergoing lung transplantation
Respiratory viral infections in stem cell transplantation
Resistant cytomegalovirus - actual management and future directions

Co-arranged with ESGICH - ESCMID SG for Infections in Compromised Hosts

Therapy of MDR/XDR Gram-negative bacteria: dealing with the devil
CRE: combination or mono-therapy?
CRE: high dosing, how much?
XDR Pseudomonas aeruginosa: what is left?
New drugs for MDR Gram-negatives: time for stewardship

Co-arranged with EUCAST - European Committee on Antimicrobial Susceptibility Testing

Novel approaches for rapid phenotypic resistance testing
Optical spectroscopy and bacterial nanocultures for rapid multiplexed phenotypic AST and UPEC biofilm diagnostics
Unraveling antimicrobial susceptibility of bacterial networks on micropillar architectures using intrinsic phase-shift spectroscopy
Microscopic imaging AST: where are we and where do we go?
Proteomic AST: from maldi to antibody … and beyond!

Transmission of pathogens and molecular phylogenetics: a forensic perspective
Phylogenetics in outbreaks and transmission of pathogens. A forensic perspective
NGS in forensics: advantages and problems
Molecular markers for forensic microbiology: from surveillance typing to metagenomics
To be or not to be: presentation of the evidence at the court

Co-arranged with ESGFOR - ESCMID SG for Forensic and Postmortem Microbiology, ESGEM - ESCMID SG for Epidemiological Markers, ISID - Israeli Society for Infectious Diseases

The clinical microbiology laboratory in 2020
The clinical microbiology laboratory in a centralized and decentralized setting
Syndrome-specific infectious disease diagnostic panels
Rapid detection of resistance mechanisms
Point-of-care testing in clinical microbiology

Co-arranged with ESGMD - ESCMID SG for Genomic and Molecular Diagnostics & the Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada)

Magic bullets for the third millennium: innovative strategies to improve antibiotic delivery to their action sites
Siderophore-antibiotic conjugates - diverting iron uptake to deliver drugs inside bacteria
Cellular targeting and trafficking of drug delivery systems for the treatment of intracellular infections: the example of TB
Harnessing the power of lasers and nanoparticles to enhance delivery of antimicrobial agents into biofilms
Pathways and progress in improving anti-infective drug delivery through the intestinal mucosa and blood-brain barriers

Advances in antimicrobial stewardship
Advances in stewardship study designs: show us the DOOR!
Methods for assessing and comparing prescribing quality
Staffing and cost-effectiveness of antimicrobial stewardship programmes
Breaking down barriers to antimicrobial stewardship programme implementation

Co-arranged with ESGAP - ESCMID SG for Antimicrobial stewardshiP

Early antimicrobial drug development news
The growing family of LpxC inhibitors
The future of beta-lactamase inhibitors
The diversity of AMP mimetics
Extending the spectrum of pleuromutilins to MDR Gram-negatives

Controversies in fungal infection management
Pro/con debate: Isavuconazole (not amphotericin B) as primary treatment for mucormycosis
Pro/con debate: Amphotericin B (not isavuconazole) as primary treatment for mucormycosis
Pro/con debate: In vitro susceptibility testing IS useful in the management of heavily immunosuppressed patients with haematologic cancer and aspergillosis
Pro/con debate: In vitro susceptibility testing IS NOT useful in the management of heavily immunosuppressed patients with haematologic cancer and aspergillosis

Co-arranged with International Immunocompromised Host Society (ICHS)

Bad news from fungi: emerging multidrug-resistant species
Who is Candida auris?
How should we manage the C. auris outbreak?
MDR-Aspergillus
MDR-fungi and patients' outcomes

Molecular diagnosis of fungal infections: where are we?
Candida
Aspergillus
Pneumocystis jirovecii

Resistance detection by molecular methods

Better tests, better care: improved diagnosis for parasitic diseases
Malaria
Schistosomiasis
Neurocysticercosis
Microsporidiosis: Enterocytozoon bieneusi infection

News in malaria treatment and control
Malaria control: current and novel interventions
Asymptomatic falciparum malaria: to treat or not to treat?
Artemisinin resistance
Artemisinin-induced anaemia

Co-arranged with ESGCP - ESCMID SG for Clinical Parasitology, TAE – Trainees Association of ESCMID

Emerging and reemerging water-borne pathogens
Amoeba and Legionella
Soil and water - Burkholderia pseudomallei niches
Cyclospora and Cryptosporidium
Parasites where you did not expect them: Angiostrongylus, Schistosoma, Opistorchis et al. in Europe

Co-arranged with ESGCP - ESCMID SG for Clinical Parasitology, EFWISG - ESCMID Food- and Water-borne Infections SG, Société Française de Microbiologie (SFM), ESGLI - ESCMID SG for Legionella Infections, ESGMYC - ESCMID SG for Mycobacterial Infections

Epidemiology of multiresistant Escherichia coli: game of clones
The growing disease burden of E. coli
Real-time WGS for national public health surveillance of E. coli extraintestinal clinical isolates
The larger world of E. coli as a commensal and pathogen in diverse hosts - a deep dive into specific ExPEC lineages
ST131: a recipe for a "superbug"

Polymicrobial biofilms and microbiome: role in respiratory tract infections
Lung infections in cystic fibrosis: beyond the usual suspects
Microbial ecology of chronic rhinosinusitis
Role of the bronchial microbiome in chronic obstructive pulmonary disease
The role of polymicrobial interactions in respiratory and middle ear infections

Co-arranged with ESGB - ESCMID SG for Biofilms

Group A Streptococcus in children and adults: from clinics to pathophysiology to treatment
Pharyngitis and beyond – to treat or not to treat – a paediatricians perspectiveINFECT: a European collaborative project utilizing a systems medicine approach to advance understanding of the pathogenesis of necrotizing soft tissue infections
Antibiotics and beyond for treating invasive GAS infections
Group A Streptococcus vaccines – almost there?

Why antibiotics fail in chronic infection therapy
Biofilms in bone and joint infections: state-of-the-art
Resistance and adaptation in chronic infections
‘omic analyses of antimicrobial resistance and tolerance
Putting tolerance in its place - practical treatment guidelines

Unraveling the secrets of bacterial virulence
Single molecule super-resolution imaging of proteins in living Salmonella enterica
Dual Seq reveals insights into host-pathogen cross talk
New genome editing technology to uncover key interactions between foodborne bacterial pathogens and human cells
What makes pathogens emerge? The case of Salmonella Typhimurium

Goods and bads of human microbiota
The microbiota, metabolism and cardiovascular health
Cross talk between commensals and the host’s immune system in mediating colonization resistance
The vaginal microenvironment as a modulator of HIV/STI risk: current understanding
Association between changes in the microbiota and obesity and asthma

Co-arranged with ESGARS - ESCMID SG for Antimicrobial Resistance Surveillance, ESGAI - ESCMID SG for Anaerobic Infections, Anaerobe Society of the Americas (ASA)

From the lab to the clinic and back: diagnosis and treatment of biofilm-related infections
How to accurately diagnose infections caused by multispecies biofilms?
Chronic wounds: what’s in the deep?
Biofilms as hot spots for development of antibiotic resistance
Clinical and molecular biofilm diagnostics

Co-arranged with ESGB - ESCMID SG for Biofilms, ESGIAI - ESCMID SG for Implant-Associated Infections

New insights into innate immunity
Innate lymphoid cells
Macrophage ontogeny, activation and function
Inflammasomes in antimicrobial host defenses 
Trained immunity 

Infections and biologicals: a real concern?
New biological therapies: introduction to the basis of the risk for infection
Current risk of anti-TNF drugs
Tyrosine kinase inhibitors: a threat?
Immunotherapy (T-cell checkpoint blockade): what to expect?

Co-arranged with ESGICH - ESCMID SG for Infections in Compromised Hosts

Barriers to infection prevention and stewardship in elderly populations
Minimising the risk of infections in geriatric wards: challenges and innovation 
Promotion of infection prevention: interventions for improving health literacy in the elderly population 
Vaccination campaign for elderly people: exploring drivers of failure and of effectiveness around the world
Do our older patients and their caregivers understand our antibiotic prescriptions?
How to improve our communication skills

Co-arranged with ESGIE - ESCMID SG for Infections in the Elderly

Update on CNS infections
NGS for diagnosis of brain infections
Challenges in managing post-neurosurgical meningo-ventriculitis and CSF shunt infections
Update on tick-borne encephalitis
Update on neurotuberculosis

Co-arranged with TAE – Trainees Association of ESCMID, ESGBOR - ESCMID SG for Lyme Borreliosis, ESGIB - ESCMID SG for Infectious Diseases of the Brain, Infectious Diseases Society of America (IDSA)

Clinical Grand Rounds
Co-arranged with Infectious Diseases Society of America (IDSA)

Newsletter Sign Up

Get regular updates on ECCMID - sign up for our newsletter!